Products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC20331	Capstafin	Capstafin is a phosphorylation of capsaicinoid derivative that acts as a highly potent, selective inhibitor of STAT5b with Ki of 0.34 uM.
DC8975	Captopril	Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).
DC21586	Capzimin	Capzimin (Rpn11 inhibitor 3027) is a derivative of 8TQ, and potent and specific inhibitor of proteasome isopeptidase Rpn11 with IC50 of 0.34 uM, >7-fold improved potency over 8TQ (quinoline-8-thiol).
DC9193	Carbamazepine Featured	Carbamazepine, a sodium channel blocker, is an anticonvulsant drug.
DCAPI1210	Carbazochrome sodium sulfonate	Carbazochrome sodium sulfonate
DC9173	Carbetapentane citrate	Carbetapentane citrate is a selective inhibitor of the cough, with mild atropine-like effect and local anesthesia effect.
DC10222	CarbinoxaMine Maleate	Carbinoxamine maleate is a histamine-H1 receptor blocking agent with antihistamine and anticholinergic properties.
DC9095	Carboplatin Featured	Carboplatin is a chemotherapy drug by binding to DNA and interfering with the cell's repair mechanism.
DC8705	Carbosulfan	Carbosulfan inhibited relatively potently CYP3A4 and moderately CYP1A1/2 and CYP2C19 in pooled HLM (human livers). Carbosulfan activation is predominantly catalyzed in humans by CYP3A4.
DC12087	Carboxy pyridostatin trifluoroacetate salt	Carboxy pyridostatin trifluoroacetate salt has the peculiarity to exhibit high molecular specificity for RNA over DNA G4s.
DC9384	Carboxypeptidase G2 (CPG2) Inhibitor Featured	Carboxypeptidase G2 (CPG2) Inhibitor is a novel Carboxypeptidase G2 (CPG2) Inhibitor, Antitumor agents.
DC6502	cardamonin Featured	Cardamonin, isolated from the fruits of Alpinia species, is a chalconoid with anti-inflammatory and anti-tumor activity.
DC8456	Cardiogenol C (hydrochloride) Featured	Cardiogenol C is a diaminopyrimidine that induces cardiomyogenesis in mouse embryonic stem cells.
DC24127	Cardiogenol C hydrochloride	Cardiogenol C is a small cell-permeable molecule that selectively and efficiently induce mouse embryonic stem cells (ESCs) to differentiate into cardiomyocytes with EC50 of 0.1 uM.
DC23875	Cardionogen 1	Cardionogen 1 (CDNG1) is a small molecule that promotes cardiomyocyte generation by modulating Wnt signaling.
DC23881	Cardionogen 2	Cardionogen 2 (CDNG2) is a small molecule that promotes cardiomyocyte generation by modulating Wnt signaling.
DC1002	Carfilzomib (PR-171) Featured	Carfilzomib is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells,showed potent activity against COVID-19(SARS-COV-2).
DC7990	Cariporide	Cariporide is a selective Na+/H+ exchanger isoform 1 (NHE1) inhibitor (IC50 values are 0.05, 3 and 1000 μM for NHE1, NHE3 and NHE2 respectively).
DC8054	Cariprazine (RGH-188) Featured	Cariprazine (RGH-188) is a novel putative antipsychotic drug that exerts partial agonism at dopamine D2/D3 receptors, with preferential binding to D3 receptors, and partial agonism at serotonin 5-HT1A receptors.
DC9012	Carisoprodol	Carisoprodol is a centrally acting skeletal muscle relaxant of the carbamate class and produces all the effects associated with barbiturate receptor ligands.
DC21875	CARM1 inhibitor 9	CARM1 inhibitor 9 is a potent, selective inhibitor of arginine methyltransferase 1 (CARM1, PRMT4) with IC50 of 94 nM.
DC24110	CARM1-IN-1 Featured	CARM1-IN-7g is a potent, selective coactivator-associated arginine methyltransferase 1 (CARM1) with IC50 of 8.6 uM, exhibits lower or no activity against a panel of different PRMTs or HKMTs (>80-fold over PRMT1 and SET7).
DC8972	Carmustine Featured	Carmustine is a cell-cycle phase nonspecific alkylating antineoplastic agent.
DC20119	Carnostatine (SAN9812)	Carnostatine (SAN9812) is a specific and highly selective carnosinase (CN1) inhibitor with a Ki of 11 nM.
DC11354	Carteolol (hydrochloride)	Carteolol is an antagonist of β-adrenergic receptors (Kd = 13 nM).
DC8113	Carubicin Featured	Carubicin is an anthracycline antineoplastic antibiotic isolated from the bacterium Actinomadura carminata.
DC9119	Carvedilol	Carvedilol(BM14190) is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation.
DC10539	POL1 inhibitor(POL1-IN-1) Featured	CAS 1822358-25-7
DC11250	Casein Kinase inhibitor A51 Featured	Casein Kinase inhibitor A51 (CKIα inhibitor A51) is a novel pan-specific CKI (CSNK1) inhibitor (Kd=0.5-20 nM, CKIα Kd=5.3 nM) that co-targets the transcriptional kinases CDK7 and CDK9, with hardly inhibition of CDK8, CDK13, CDK11a, CDK11b, and CDK19; target both CDK7 and CDK9 with low nM Kd values; induces leukemia cell apoptosis at <160 nM, in correlation to the capacity to stabilize p53; shows high and selective sensitivity against leukemic CFUs in colony-forming unit (CFU) assay, without effect on normal hematopoietic CFUs; blocking CKIα together with CDK7 and/or CDK9 synergistically stabilize p53, deprive leukemia cells of survival and proliferation-maintaining SE-driven oncogenes, induce apoptosis, abolishes the expression of MYC, MDM2, and the anti-apoptotic oncogene MCL1; demonstrates therapeutic efficacy with preserved hematopoiesis and leukemia cure potential in AML mouse models.
DC11251	Casein Kinase inhibitor A86 Featured	CKIα inhibitor A86 is a groundbreaking pan-specific inhibitor targeting Casein Kinase I (CSNK1), with a remarkable binding affinity (Kd=1-10 nM) and a specific Kd of 9.8 nM for CKIα. Beyond its primary activity, this compound also demonstrates dual inhibitory effects on the transcriptional kinases CDK7 and CDK9. Notably, it exhibits minimal to no inhibition against CDK8, CDK13, CDK11a, CDK11b, and CDK19, highlighting its selective pharmacological profile.

Products

Customized Consultation X

Your information is safe with us. * Required Fields.